JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1887K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kean, L. S.
Right arrow Articles by Nichols, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kean, L. S.
Right arrow Articles by Nichols, J. W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1997//255 $5.00
The Journal of Cell Biology, Volume 138, Number 2, , 1997 255-270

Article

Plasma Membrane Translocation of Fluorescent-labeled Phosphatidylethanolamine Is Controlled by Transcription Regulators, PDR1 and PDR3



Leslie S. Kean*, Althea M. Grant*, Cesar Angeletti*, Yannick Mahé§, Karl Kuchler§, Robert S. Fuller{ddagger}, and J. Wylie Nichols*

* Department of Physiology, Emory University School of Medicine, Atlanta, Georgia 30322; {ddagger} Department of Biological Chemistry, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0606; and § Department of Molecular Genetics, University of Vienna, A-1030 Vienna, Austria

The transcription regulators, PDR1 and PDR3, have been shown to activate the transcription of numerous genes involved in a wide range of functions, including resistance to physical and chemical stress, membrane transport, and organelle function in Saccharomyces cerevisiae. We report here that PDR1 and PDR3 also regulate the transcription of one or more undetermined genes that translocate endogenous and fluorescent-labeled (M-C6-NBD-PE) phosphatidylethanolamine across the plasma membrane. A combination of fluorescence microscopy, fluorometry, and quantitative analysis demonstrated that M-C6-NBD-PE can be translocated both inward and outward across the plasma membrane of yeast cells. Mutants, defective in the accumulation of M-C6-NBD-PE, were isolated by selectively photokilling normal cells that accumulated the fluorescent phospholipid. This led to the isolation of numerous trafficking in phosphatidylethanolamine (tpe) mutants that were defective in intracellular accumulation of M-C6-NBD-PE. Complementation cloning and linkage analysis led to the identification of the dominant mutation TPE1-1 as a new allele of PDR1 and the semidominant mutation tpe2-1 as a new allele of PDR3. The amount of endogenous phosphatidylethanolamine exposed to the outer leaflet of the plasma membrane was measured by covalent labeling with the impermeant amino reagent, trinitrobenzenesulfonic acid. The amount of outer leaflet phosphatidylethanolamine in both mutant strains increased four- to fivefold relative to the parent Tpe+ strain, indicating that the net inward flux of endogenous phosphatidylethanolamine as well as M-C6-NBD-PE was decreased. Targeted deletions of PDR1 in the new allele, PDR1-11, and PDR3 in the new allele, pdr3-11, resulted in normal M-C6-NBD-PE accumulation, confirming that PDR1-11 and pdr3-11 were gain-of-function mutations in PDR1 and PDR3, respectively. Both mutant alleles resulted in resistance to the drugs cycloheximide, oligomycin, and 4-nitroquinoline N-oxide (4-NQO). However, a previously identified drug-resistant allele, pdr3-2, accumulated normal amounts of M-C6-NBD-PE, indicating allele specificity for the loss of M-C6-NBD-PE accumulation. These data demonstrated that PDR1 and PDR3 regulate the net rate of M-C6-NBD-PE translocation (flip-flop) and the steady-state distribution of endogenous phosphatidylethanolamine across the plasma membrane.

Abbreviations used in this paper: 4-NQO, 4-nitroquinoline N-oxide; DAPI, 4',6-diamidino-2-phenylindol; DIC, differential interference contrast; DOPC, dioleoylphosphatidylcholine; M-C6-NBD-PC, 1-myristoyl-2-[6-(NBD) aminocaproyl]-phosphatidylcholine; M-C6-NBD-PE, 1-myristoyl-2-[6-(NBD) aminocaproyl]-phosphatidylethanolamine; NBD, 7-nitrobenz-2-oxa-1,3- diazol-4-yl; NBD-PE, 1-acyl-2-[6-(NBD) aminocaproyl]-phosphatidylethanolamine; N-Rh-DOPE, N-rhodamine-dioleoylphosphatidylethanolamine; NEM, N-ethlymaleimide; TLC, thin-layer chromatography; TNBS, trinitrobenzenesulfonic acid; tpe, trafficking of phosphatidylethanolamine.

Please address all correspondence to J. Wylie Nichols, Department of Physiology, Emory University School of Medicine, Atlanta, GA 30322. Tel.: (404) 727-7422. Fax: (404) 727-2648. E-mail: wnichols{at}physio.emory.edu

Leslie S. Kean and Althea M. Grant made equivalent contributions to the work presented and should be considered co-first authors.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents